Home > Boards > US OTC > Medical - Healthcare > Todos Med Ltd (TOMDF)

Inside the 8-k current report on 6/28/2021, one

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Mister Silver Member Profile
 
Followed By 3
Posts 92
Boards Moderated 0
Alias Born 06/14/21
160x600 placeholder
Todos Medical concludes Phase 2 trial for COVID-19 therapy after meeting main goal Seeking Alpha - 1/27/2022 9:29:37 AM
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients InvestorsHub NewsWire - 1/27/2022 8:30:48 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/18/2022 4:04:29 PM
Todos Medical signs 90-day agreement extension with convertible note holders Seeking Alpha - 12/13/2021 9:04:05 AM
SA Breaking News - PURA expects to sign first contracts this month InvestorsHub NewsWire - 12/2/2021 10:39:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2021 4:02:25 PM
Todos Medical to acquire all 3CL protease biology-related assets and intellectual property from NLC Pharma Seeking Alpha - 11/29/2021 10:09:41 AM
Todos Medical inks licensing deal with T-Cell Protect forTtollovid products in Europe Seeking Alpha - 11/24/2021 2:58:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2021 6:09:53 AM
Todos Medical reports Q3 results Seeking Alpha - 11/16/2021 5:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2021 3:06:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 6:06:16 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/24/2021 9:59:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2021 9:25:51 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/24/2021 6:00:59 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/15/2021 4:18:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/27/2021 4:33:24 PM
Todos Medical inks distribution agreement with Fosun Pharma for COVID-19 test kit Seeking Alpha - 7/19/2021 9:02:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2021 4:02:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2021 10:43:45 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/7/2021 4:02:57 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/6/2021 4:02:51 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/30/2021 4:03:26 PM
Todos Medical Ltd. reports Q1 results Seeking Alpha - 6/29/2021 11:24:03 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/29/2021 9:22:52 AM
Mister Silver   Thursday, 07/01/21 11:42:41 AM
Re: JoeForkeyBolo post# 3000
Post # of 6804 
Inside the 8-k current report on 6/28/2021, one of the aspects being voted on - the first proposition in the vote is as follows...

Sections (a) - (c) deal with allocating shares.

Section (d) - "to allow the company to fulfill relevant provisions of U.S. law in lieu of Israeli law requirements regarding external directors, if and to the extent allowed to do so under Israeli corporate law and regulation."

Kind of makes one wonder about the whole aspect regarding Israeli law and authorized shares quoted in the update..

“it is important to note that under Israel law, there can only be a proportional split of issued and authorized shares, meaning that if there is a reverse split of the outstanding shares 1:10, then there must be a proportional reverse split of the authorized shares by the same 1:10 ratio."

You placed that print in all caps in your comment, might as well give the full picture where they are voting to disregard aspects of Israeli law.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences